Zynex, Inc. Common Stock
ZYXI US98986M1036
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -28% | 53% | -22% | -26% | 4% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Sandgaard Thomas CEO |
2.91 USD |
1,700,000 Sold |
4,938,500 USD |
13/03/2025 | 13/03/2025 |
| Moorhead Daniel J CFO |
7.15 USD |
10,000 Sold |
71,500 USD |
03/03/2025 | 03/03/2025 |
| Moorhead Daniel J CFO |
7.68 USD |
10,000 Sold |
76,800 USD |
03/02/2025 | 03/02/2025 |
| Moorhead Daniel J CFO |
7.88 USD |
10,000 Sold |
78,800 USD |
02/01/2025 | 02/01/2025 |
| Moorhead Daniel J CFO |
8.08 USD |
10,000 Sold |
80,800 USD |
02/12/2024 | 02/12/2024 |
| Sandgaard Thomas PR |
8.09 USD |
2,000 Sold |
16,180 USD |
14/11/2024 | 14/11/2024 |
| Sandgaard Thomas PR |
8.37 USD |
2,000 Sold |
16,740 USD |
07/11/2024 | 13/11/2024 |
| Sandgaard Thomas PR |
9.24 USD |
2,000 Sold |
18,480 USD |
07/11/2024 | 12/11/2024 |
| Sandgaard Thomas PR |
9.09 USD |
2,000 Sold |
18,180 USD |
07/11/2024 | 11/11/2024 |
| Sandgaard Thomas PR |
8.77 USD |
2,000 Sold |
17,540 USD |
07/11/2024 | 08/11/2024 |